Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MC230502 Dynamic Investigator Initiated Enterprise (DIVINE) in Prostate Cancer

NCT06378866 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06378866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06378866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MC230502 Dynamic Investigator Initiated Enterprise (DIVINE) in Prostate Cancer
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Recruiting
Start date
June 3, 2024
Completion date
February 28, 2031
Enrollment
532 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

biochemically recurrent prostate carcinoma, castration-resistant prostate cancer, recurrent castration-sensitive prostate carcinoma, recurrent prostate cancer